Human prostate muscarinic receptor subtypes

Area of Science:

• Pharmacology
• Molecular Biology
• Urology

Background:

• While alpha adrenergic receptors in the human prostate are well-studied, muscarinic receptor subtypes remain largely uncharacterized.
• Understanding muscarinic receptor function is crucial for prostate physiology and potential therapeutic interventions.

Purpose of the Study:

• To determine the subtypes and functional characteristics of muscarinic receptors in human prostate adenoma.
• To investigate the specific localization and signaling partners of identified muscarinic receptor subtypes.

Main Methods:

• Radioligand binding assays using [3H]-QNB to quantify total muscarinic receptor density.
• Pharmacological characterization using subtype-selective antagonists (pirenzepine, hexahydrosiladifenidol, methoctramine).
• Immunoprecipitation and immunohistochemistry to identify receptor subtypes and their cellular localization.

Main Results:

• Prostate adenoma membranes exhibited a high density of muscarinic receptors (46 fMol/mg protein).
• M1-selective ligands potently inhibited [3H]-QNB binding, indicating M1 receptor predominance.
• Immunoprecipitation confirmed M1 as the major subtype (~75%), with minimal presence of M2, M3, or M4.
• M1 receptors co-immunoprecipitated with Gi alpha, Gq/11 alpha, and G16 alpha G proteins upon agonist stimulation.
• Immunohistochemistry localized M1 receptors to the glandular epithelium.

Conclusions:

• The human prostate adenoma predominantly expresses the M1 muscarinic receptor subtype.
• M1 receptors in the prostate associate with specific G proteins, suggesting distinct signaling pathways.
• This is the first report demonstrating a M1 muscarinic receptor preponderance in a peripheral tissue.